Pfizer INDovation Program Selects 20 Promising Healthcare Startups for IP and Commercialization Support
India’s healthcare startup ecosystem received a significant boost as innovators, policymakers, healthcare leaders and investors gathered at IIT Delhi for a major discussion on the future of healthcare innovation and intellectual property-led growth.
Organized by the Foundation for Innovation and Technology Transfer (FITT) at IIT Delhi in partnership with Pfizer India under its Corporate Social Responsibility initiative and innovation platform Social Alpha, the event titled “Translating What’s Next: Securing the Future of Innovation” focused on accelerating India’s journey toward becoming a global healthcare innovation powerhouse.
The gathering served as a platform to examine how stronger intellectual property frameworks, commercialization strategies and ecosystem partnerships can help transform breakthrough healthcare ideas into scalable businesses and impactful solutions.
20 Healthcare Startups Chosen Under Pfizer INDovation Program
One of the event’s key announcements was the selection of 20 startups under the Pfizer INDovation Program (IP Support Edition) 2025–26.
Designed specifically for healthcare and biotechnology innovators, the program aims to strengthen startup capabilities in intellectual property protection, technology commercialization and investor readiness. Selected startups will receive expert guidance on patent strategy, legal support, commercialization planning and mentorship from industry professionals.
The initiative also provides opportunities to connect with investors and venture capital firms, helping founders navigate the path from innovation to market adoption.
According to organizers, intellectual property remains one of the most important yet underutilized assets for emerging healthcare ventures. By helping startups build robust IP portfolios early, the program seeks to enhance their competitiveness in both domestic and international markets.
Experts Discuss India’s Healthcare Transformation
The event featured a series of keynote addresses from leaders representing healthcare, public policy and innovation ecosystems.
Dr. M. Srinivas, Former Director of AIIMS New Delhi and Member (Health), NITI Aayog, highlighted the growing role of digital infrastructure in reshaping healthcare delivery across India. He noted that initiatives such as the Ayushman Bharat Digital Mission are creating the foundation for a more connected and accessible healthcare system.
Representing the government’s startup ecosystem initiatives, Shri Bhuvnesh Pratap Singh, Director, Startup India, emphasized the importance of entrepreneurship and technology-led healthcare solutions in achieving India’s long-term development ambitions.
The role of collaboration between research institutions and industry also emerged as a central theme.
Tarun Chaturvedi, Chief Operating Officer of FITT IIT Delhi, spoke about the challenges many innovations face while transitioning from laboratories to real-world implementation. He stressed that stronger partnerships among researchers, startups and industry stakeholders are essential for ensuring that scientific breakthroughs reach patients and healthcare providers.
From an industry perspective, Sharad Goswami, Senior Director, Global Policy and International Public Affairs at Pfizer India, highlighted the importance of cross-sector collaboration in driving sustainable healthcare innovation. He emphasized that innovation ecosystems built on partnerships can help accelerate the development and adoption of impactful healthcare technologies.
Conversations Focus on Innovation Protection and Market Readiness
The event also featured expert-led panel discussions addressing critical issues facing healthcare startups.
One discussion explored what makes healthcare innovation defensible in a competitive global environment, focusing on intellectual property strategy, scientific validation and commercialization readiness.
Another session examined the growing importance of regulatory planning, encouraging startups to view regulatory frameworks not simply as compliance requirements but as strategic tools that can support long-term growth and market expansion.
Industry experts noted that startups that incorporate regulatory and IP considerations early in their development journey often gain stronger competitive advantages and attract greater investor confidence.
A Growing Opportunity for Healthcare Entrepreneurs
India’s healthcare innovation landscape has expanded rapidly in recent years, supported by advancements in digital health infrastructure, increasing venture capital interest, supportive policy initiatives and a growing community of deep-tech entrepreneurs.
Programs such as Pfizer INDovation are helping address some of the most critical challenges faced by early-stage ventures by providing access to expertise, networks and commercialization resources.
The initiative reflects a broader effort to create an environment where healthcare innovators can move beyond product development and successfully build globally relevant businesses.
Key Highlights of the Program
- 20 healthcare and biotech startups selected through a competitive evaluation process
- Dedicated intellectual property and patent strategy support
- Access to industry mentors, investors and venture capital networks
- Commercialization guidance aimed at accelerating market entry
- Focus on integrating regulatory strategy into startup growth planning
As India continues to strengthen its innovation ecosystem, collaborations between academia, industry and policy stakeholders are expected to play an increasingly important role in shaping the future of healthcare technologies and improving access to advanced healthcare solutions both in India and globally.
Last Updated on Wednesday, June 3, 2026 11:05 am by Startup Chronicle Team
About The Author
